EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2 - Roshdy, Wael H.; Rashed, Helmy A.; Kandeil, Ahmed; Mostafa, Ahmed; Moatasim, Yassmin; Kutkat, Omnia; Abo Shama, Noura M.; Gomaa, Mokhtar R.; El-Sayed, Ibrahim H.; El Guindy, Nancy M.; Naguib, Amal; Kayali, Ghazi; et al. (PloS one, 2020)
Keywords: Active Transport, Cell Nucleus - drug effects; Animals; Antiviral activity; Antiviral agents; Antiviral Agents - pharmacology; Antiviral drugs; Bioavailability; Biology and life sciences; Care and treatment; Cell lines; Cell Nucleus - drug effects; Cell Nucleus - metabolism; Chlorocebus aethiops; Coronaviruses; COVID-19; Curcuma - chemistry; Curcumin; Cytokine storm; Cytokines; Disease; Funding; Health aspects; Herbal medicine; Humans; Immune response; Immunologic Factors - pharmacology; Immunomodulation; Immunomodulators; Infections; Influenza; Interleukin 6; Interleukin-6 - metabolism; Kinetics; Laboratories; Mass spectrometry; Medicine and health sciences; Mitochondrial DNA; NF-kappa B p50 Subunit - metabolism; NF-KappaB Inhibitor alpha - metabolism; Nuclear transport; Pandemics; Pathogenesis; Physical Sciences; Piper nigrum; Piper nigrum - chemistry; Plant extracts; Plant Extracts - pharmacology; Population; Public health; Research and Analysis Methods; Respiratory diseases; SARS-CoV-2 - drug effects; Scientific imaging; Seeds; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Supervision; Testing; Translocation; Tumor Necrosis Factor-alpha - metabolism; Tumor necrosis factor-α; Vaccines; Vero Cells; Viral diseases; Viral infections; Viruses; Egypt; Cairo Egypt; United States--US; Giza Egypt